Actinobacteria

This book summarizes the basics of actinobacteria, from microbiology to synthetic biology. It focuses on diversity, NRPS, sesquiterpenes, lantipeptide, bioinformatics apparatuses, cloning, CRISPR, reverse engineering, FDA supported medications, and marine actinobacteria. It also covers the latest trends in drug discovery from actinobacteria, and introduces several recently developed bioinformatics and synthetic biology tools to explore new antibiotics from actinobacteria.

Many natural products such as polyketides, isoprenoids, phenazines, peptides, indolocarbarbazoles, sterols, and others have been isolated and characterized from actinobacteria. Some products are synthesized by the non-ribosomal peptide synthetases (NRPSs), polyketide synthases (PKSs), or other functional genes. Although genome sequencing has uncovered the differing qualities of these chemicals, recognizing new items and their biosynthetic pathways is still under examination.

Cryptic metabolic pathwayshave been explored using molecular techniques or culture-dependent approaches. In recent years, researchers' primary interest is to identify the specific conditions or agents that wake the cryptic antibiotics. Several bioinformatics and synthetic biology tools were developed to explore new antibiotics from actinobacteria.

The book comprises 14 chapters with different aspects of application and utilization of actinomycetes from the microbiology; systems biology, pharmacology of natural products, bioinformatics, actinomycete and its diversity, CRISPR, artificial Intelligence, synthetic biology, metabolic engineering, expressional studies, and biosynthetic gene clusters.

The book delivers useful information on actinomyces to researchers, novices in genome designing, specialists, clinicians, policymakers, and professionals.

Summarizes to the latest trends for drug discovery from actinobacteria Introduces recent bioinformatics and synthetic biology tools Explains the diversity of actinobacteria

Auteur
Dr. Loganathan Karthik has an extensive expertise in Actinobacteria and Drug Discovery Strategies and is presently working as a Project Lead-Synthetic biology at Salem Microbes Pvt. Ltd, Salem, India. He is an elected Fellow member of Linnean Society of London. He did first postdoctoral training at the Shanghai Jiao Tong University, China under the guidance of eminent scientist Prof. Zhiyong Li. Further he has completed his second postdoctoral fellowship in ECUST, Shanghai, China under the guidance of eminent scientist Prof. Lixin Zhang. He received his Ph.D. degree in Microbiology from the VIT University in 2013. He had published around 100 research papers, 3 Books and 6 patents. He is a Communication committee member of International Chemical Biology Society, USA and President of Society of Chemical and Synthetic biology, India. In 2016, he got Prestigious "Young Scientist Award" from Indian Association of Applied Microbiologists for his outstanding research work. andalso, he got Best Research scholar award-2012 from VIT University. He got 200 young scientist-2012 fellowship (DST) for to attend International conference.

Contenu
Chapter 1. Actinomycetes: Microbiology to Systems Biology.- Chapter 2. Diversity of actinobacteria in various habitats.- Chapter 3. Traditional Screening and Genome Guided Screening of Natural Products from Actinobacteria.- Chapter 4. The relationship between actinobacteria and rice.- Chapter 5.Non-ribosomally and ribosomally synthesized bioactive peptides NRPS and RiPPs from actinobacteria.- Chapter 6. Genome Data Mining, Chemistry and Bioactivity of Sesquiterpenes from Actinobacteria.- Chapter 7. Genome Data Mining, Chemistry and Bioactivity of Sesquiterpenes from Actinobacteria.- Chapter 8. Cloning and Heterologous expression of Natural products from Actinobacteria.- Chapter 9. Synthetic Biology and Metabolic Engineering in Actinobacteria for Natural Product Production.- Chapter 10. CRISPR ERA: CURRENT APPLICATIONS AND FUTURE PERSPECTIVES ON ACTINOBACTERIA.- Chapter 11. Uncultured Actinobacteria and Reverse engineering and Artificial Intelligence role in future.- Chapter 12. Cultivation and Diversity of Marine Actinomycetes: Molecular Approaches and Bioinformatics Tools.- Chapter 13. Antimicrobial Potential and Metabolite Profiling of Marine Actinobacteria.- Chapter 14. Pharmacology of FDA Approved Medicines from Actinobacteria.